ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

picankibart

Its studies are mostly in Psoriasis · Arthritis, Psoriatic, led by Innovent Biologics.

Drug pagePicankibart: every studyAll 3 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Apr 18, 20252 company-led studies, 2 open or runningNext primary completion: Dec 31, 2029 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Innovent Biologics22 open or runningphase 3since Apr 18, 2025Apr 18, 2025Dec 31, 2029phase 3 · NCT07295509

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.

  1. Jan 19, 2023Named picankibartINNProposed as its International Nonproprietary Name in WHO's List 128
  2. Apr 18, 2025First study: phase 3 study in Plaque PsoriasisFirst studyNCT06945107 · 308 enrolled · China
  3. Nov 24, 2025Phase 3 study in Arthritis, PsoriaticNCT07295509 · 222 planned · China

Ahead

  1. Dec 31, 2029Primary completion: phase 3 study in Arthritis, PsoriaticNCT07295509

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07295509Arthritis, Psoriatic · China3RecruitingDec 31, 2029222
NCT06945107Plaque Psoriasis · China3Active, not recruitingJun 7, 2026308

How it is read

Names in the registry

  • “Picankibart”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
picankibart (Innovent Biologics): development program | ClinicalTrials.gg